Skip to main content
Top
Published in: Current Gastroenterology Reports 11/2017

01-11-2017 | GI Oncology (R Bresalier, Section Editor)

Endoscopic and Imaging Predictors of Complete Pathologic Response After Chemoradiation for Esophageal Cancer

Authors: Guneesh S. Uberoi, Angad S. Uberoi, Manoop S. Bhutani

Published in: Current Gastroenterology Reports | Issue 11/2017

Login to get access

Abstract

Purpose of Review

Locally advanced esophageal cancer is frequently treated preoperatively with chemotherapy and radiation. The degree of response to this preoperative therapy varies in different patients, and a complete pathological response (pCR) has important implications in the management and prognosis of these patients. This is a review of the different modalities currently available to detect pCR and the clinical context of their use.

Recent Findings

While research is still ongoing, no single technique has emerged as the modality of choice to reliably predict pCR in all patients. Studies investigating the sensitivity, specificity, and accuracy of these modalities have had promising results, but no single modality has been firmly validated as the modality if choice. The emergence of functional imaging techniques and the use of biomarkers are newer developments which need further evaluation before adoption in routine clinical practice.

Summary

While no single technique reliably predicts pCR, a combination of imaging and diagnostic modalities (endoscopic appearance, biopsy, EUS, and PET/CT) may provide a better diagnostic yield rather than any of these modalities taken alone.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0 CIaMWICNI, Lyon FIAfRoCAfhgif. Accessed 19 Apr 2017. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0 CIaMWICNI, Lyon FIAfRoCAfhgif. Accessed 19 Apr 2017.
11.
go back to reference Vogel SB, Mendenhall WM, Sombeck MD, Marsh R, Woodward ER. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg. 1995;221(6):685–95.CrossRefPubMedPubMedCentral Vogel SB, Mendenhall WM, Sombeck MD, Marsh R, Woodward ER. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg. 1995;221(6):685–95.CrossRefPubMedPubMedCentral
13.
go back to reference Cheedella NKS, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, et al. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol. 2013;24(5):1262–6. https://doi.org/10.1093/annonc/mds617.CrossRefPubMed Cheedella NKS, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, et al. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol. 2013;24(5):1262–6. https://​doi.​org/​10.​1093/​annonc/​mds617.CrossRefPubMed
15.
go back to reference •• PSN VR, Goense L, Meziani J, Reitsma JB, Siersema PD, Vleggaar FP, et al. Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis. Gastrointest Endosc. 2016;83(5):866–79. https://doi.org/10.1016/j.gie.2015.11.026. This is a meta-analysis which demonstrates that endoscopic rebiopsy and EUS, while specific, lack the sensitivity to reliably allow physicians to withhold surgery in patients with pCR after nCRT due to a very high false-negative rate CrossRef •• PSN VR, Goense L, Meziani J, Reitsma JB, Siersema PD, Vleggaar FP, et al. Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis. Gastrointest Endosc. 2016;83(5):866–79. https://​doi.​org/​10.​1016/​j.​gie.​2015.​11.​026. This is a meta-analysis which demonstrates that endoscopic rebiopsy and EUS, while specific, lack the sensitivity to reliably allow physicians to withhold surgery in patients with pCR after nCRT due to a very high false-negative rate CrossRef
16.
go back to reference Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol. 2008;14(10):1479–90.CrossRefPubMedPubMedCentral Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol. 2008;14(10):1479–90.CrossRefPubMedPubMedCentral
17.
go back to reference Jost C, Binek J, Schuller JC, Bauerfeind P, Metzger U, Werth B, et al. Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02). Gastrointest Endosc. 2010;71(7):1114–21. https://doi.org/10.1016/j.gie.2009.12.015.CrossRefPubMed Jost C, Binek J, Schuller JC, Bauerfeind P, Metzger U, Werth B, et al. Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02). Gastrointest Endosc. 2010;71(7):1114–21. https://​doi.​org/​10.​1016/​j.​gie.​2009.​12.​015.CrossRefPubMed
18.
go back to reference Willis J, Cooper GS, Isenberg G, Sivak MV Jr, Levitan N, Clayman J, et al. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc. 2002;55(6):655–61.CrossRefPubMed Willis J, Cooper GS, Isenberg G, Sivak MV Jr, Levitan N, Clayman J, et al. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc. 2002;55(6):655–61.CrossRefPubMed
20.
go back to reference Isenberg G, Chak A, Canto MI, Levitan N, Clayman J, Pollack BJ, et al. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest Endosc. 1998;48(2):158–63.CrossRefPubMed Isenberg G, Chak A, Canto MI, Levitan N, Clayman J, Pollack BJ, et al. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest Endosc. 1998;48(2):158–63.CrossRefPubMed
22.
24.
go back to reference Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, et al. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol. 2006;1(5):478–86.CrossRefPubMed Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, et al. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol. 2006;1(5):478–86.CrossRefPubMed
25.
26.
go back to reference Jones DR, Parker LA Jr, Detterbeck FC, Egan TM. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer. 1999;85(5):1026–32.CrossRefPubMed Jones DR, Parker LA Jr, Detterbeck FC, Egan TM. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer. 1999;85(5):1026–32.CrossRefPubMed
29.
go back to reference •• van Rossum PS, van Lier AL, van Vulpen M, Reerink O, Lagendijk JJ, Lin SH, et al. Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiother Oncol. 2015;115(2):163–70. https://doi.org/10.1016/j.radonc.2015.04.027. This is a recent study evaluating functional imaging with DW-MRI and showed encouraging results with the use of tumor ADC change even in the first few weeks of nCRT, thus having the potential to limit its toxicity in non-responders CrossRefPubMed •• van Rossum PS, van Lier AL, van Vulpen M, Reerink O, Lagendijk JJ, Lin SH, et al. Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiother Oncol. 2015;115(2):163–70. https://​doi.​org/​10.​1016/​j.​radonc.​2015.​04.​027. This is a recent study evaluating functional imaging with DW-MRI and showed encouraging results with the use of tumor ADC change even in the first few weeks of nCRT, thus having the potential to limit its toxicity in non-responders CrossRefPubMed
32.
go back to reference •• Metzger R, Warnecke-Eberz U, Alakus H, Kutting F, Brabender J, Vallbohmer D, et al. Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis. J Gastrointest Surg. 2012;16(1):26–34. https://doi.org/10.1007/s11605-011-1700-x. This study evaluated the association of ERCC gene polymorphisms and histopathological response to nCRT in esophageal adenocarcinoma patients and showed that some genotypes were predictive of response to preoperative therapy CrossRefPubMed •• Metzger R, Warnecke-Eberz U, Alakus H, Kutting F, Brabender J, Vallbohmer D, et al. Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis. J Gastrointest Surg. 2012;16(1):26–34. https://​doi.​org/​10.​1007/​s11605-011-1700-x. This study evaluated the association of ERCC gene polymorphisms and histopathological response to nCRT in esophageal adenocarcinoma patients and showed that some genotypes were predictive of response to preoperative therapy CrossRefPubMed
Metadata
Title
Endoscopic and Imaging Predictors of Complete Pathologic Response After Chemoradiation for Esophageal Cancer
Authors
Guneesh S. Uberoi
Angad S. Uberoi
Manoop S. Bhutani
Publication date
01-11-2017
Publisher
Springer US
Published in
Current Gastroenterology Reports / Issue 11/2017
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-017-0594-5

Other articles of this Issue 11/2017

Current Gastroenterology Reports 11/2017 Go to the issue

Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract (S Rao, Section Editor)

Post-Infectious Irritable Bowel Syndrome

Nutrition and Obesity (S McClave and J Obert, Section Editors)

Going Gluten Free: the History and Nutritional Implications of Today’s Most Popular Diet

Nutrition and Obesity (S McClave and J Obert, Section Editors)

Phenotypes of Obesity: How it Impacts Management

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine